10,593 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Mufg Securities Americas Inc.

Mufg Securities Americas Inc. bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, Holdings Channel reports. The fund bought 10,593 shares of the pharmacy operator’s stock, valued at approximately $99,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in WBA. Norges Bank purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth approximately $58,241,000. Invesco Ltd. increased its holdings in Walgreens Boots Alliance by 8.8% in the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after acquiring an additional 2,631,332 shares in the last quarter. Vanguard Group Inc. increased its holdings in Walgreens Boots Alliance by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after acquiring an additional 2,279,495 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after acquiring an additional 2,185,950 shares in the last quarter. Finally, Amundi grew its holdings in Walgreens Boots Alliance by 70.3% during the 4th quarter. Amundi now owns 4,455,720 shares of the pharmacy operator’s stock valued at $41,082,000 after buying an additional 1,839,045 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

WBA has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a report on Tuesday, May 13th. They set a “hold” rating for the company. Finally, Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $10.59.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina bought 832,258 shares of the stock in a transaction dated Sunday, April 27th. The stock was purchased at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now owns 145,621,079 shares of the company’s stock, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Trading Up 1.0%

Shares of WBA opened at $11.29 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.17. The stock has a market capitalization of $9.76 billion, a PE ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. The company’s fifty day moving average is $11.02 and its 200 day moving average is $10.36.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to analysts’ expectations of $37.90 billion. During the same quarter in the previous year, the business posted $1.20 earnings per share. The business’s revenue was up 4.1% compared to the same quarter last year. Sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.